Copyright
©The Author(s) 2015.
World J Hepatol. Nov 28, 2015; 7(27): 2757-2764
Published online Nov 28, 2015. doi: 10.4254/wjh.v7.i27.2757
Published online Nov 28, 2015. doi: 10.4254/wjh.v7.i27.2757
Figure 2 A change of the des-gamma-carboxy prothrombin levels after interferon-based treatment.
DCP: Des-gamma-carboxy prothrombin; HCC: Hepatocellular carcinoma.
- Citation: Shakado S, Sakisaka S, Chayama K, Okanoue T, Toyoda J, Izumi N, Matsumoto A, Takehara T, Ido A, Hiasa Y, Yoshioka K, Nomura H, Ueno Y, Seike M, Kumada H. Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development. World J Hepatol 2015; 7(27): 2757-2764
- URL: https://www.wjgnet.com/1948-5182/full/v7/i27/2757.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i27.2757